{
    "2018-06-08": [
        [
            {
                "time": "",
                "original_text": "今日登A的富士康会不会被催成\"虚胖\" 14板市值超茅台",
                "features": {
                    "keywords": [
                        "富士康",
                        "A股",
                        "虚胖",
                        "14板",
                        "市值",
                        "茅台"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因:280亿市值解禁在即 百倍市盈率能否扛得住?",
                "features": {
                    "keywords": [
                        "华大基因",
                        "市值解禁",
                        "280亿",
                        "百倍市盈率"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}